Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin

  • Read more about Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin

Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials

  • Read more about Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials

Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis

  • Read more about Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis

Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

  • Read more about Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development

  • Read more about Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development

Antimicrobial resistance: concerns of healthcare providers and people with CF

  • Read more about Antimicrobial resistance: concerns of healthcare providers and people with CF

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis

  • Read more about The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis

Clinimetric evaluation of muscle function tests for individuals with cystic fibrosis: A systematic review

  • Read more about Clinimetric evaluation of muscle function tests for individuals with cystic fibrosis: A systematic review

A disruption of innervation around CF tissues results in low amount of VIP before CF disease has produced damage to the lungs and small intestine.

  • Read more about A disruption of innervation around CF tissues results in low amount of VIP before CF disease has produced damage to the lungs and small intestine.

Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins

  • Read more about Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins
  • first
  • previous
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)